Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04575051 · ClinicalTrials.gov registry record · NA

Hearing for Communication and Resident Engagement

A NA study of Hearing Loss, Age-Related, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
684
Enrollment target
1
Study location

NCT04575051: Completed NA study of Hearing Loss, Age-Related, sponsored by University of Pittsburgh.

NCT04575051 is a NA study of Hearing Loss, Age-Related that has completed, run by University of Pittsburgh. The registered enrollment target is 684 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04575051, a NA study of Hearing Loss, Age-Related, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
684 participants
Enrollment target
1
Study location

Study Summary

Amplification is a well-established, evidence-based front-line treatment for those with impaired communication secondary to Age Related Hearing Loss (ARHL). ARHL is the most prevalent cause of communication impairment among older adults. The challenge in treating ARHL is identifying a care model that effectively promotes adherence to individualized-treatment recommendations allowing the end-user to self-manage hearing loss with appropriate support. This proposal compares the two most common models of care for ARHL provided to adults in assisted living/personal care communities. The Consult Model (i.e., usual care) is an acute care strategy, relying on a monthly Audiologist visit to the facility. The Engage Model is a chronic care approach to support hearing loss self-management of ARHL. Engage includes (a) hearing screening for all residents, (b) an individualized communication plan for those with an identified hearing loss (e.g., one-to-one, group, telephone, television plans, hearing aid trouble shooting, communication strategies, etc.), (c) provision of simple, non-custom amplifiers, (d) referral to audiology if needed, and (e) ongoing support provided by trained personnel (Communication Facilitator) under the supervision of the audiologist.

Primary Outcome

PROMIS Satisfaction with Participation in Discretionary Social Activities SF7a self-reported contentment with leisure interests and relationships with friends. T- scores are provided ranging from 27 to 65.6 where higher scores indicate more satisfaction (50 indicates the population mean with a standard deviation of 10).

Conditions Studied

Interventions

  • OTHER Consult Model
  • OTHER Engage Model

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 684 participants
Start Date 2021-06-01
Est. Completion 2023-11-01
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT04575051 record still lists

NCT04575051 is an interventional study that assigns participants to a tested intervention. The registered 684 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% lower).

The record links to 1 condition, with Hearing Loss, Age-Related appearing as the primary indexed condition, and to 2 interventions - of which Consult Model is the first listed.

NCT04575051 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04575051 about?

NCT04575051 is a clinical study titled "Hearing for Communication and Resident Engagement". Amplification is a well-established, evidence-based front-line treatment for those with impaired communication secondary to Age Related Hearing Loss (ARHL). ARHL is the most prevalent cause of communication impairment among older adults. The challenge in treating ARHL is identifying a care model tha...

What is the current status of trial NCT04575051?

This trial is currently completed. It is a NA study. The enrollment target is 684 participants. The study started on 2021-06-01. Estimated completion is 2023-11-01.

What conditions does trial NCT04575051 study?

This clinical trial studies the following conditions: Hearing Loss, Age-Related.

What interventions are being tested in trial NCT04575051?

The interventions under investigation include: Consult Model (OTHER), Engage Model (OTHER).

Who is sponsoring clinical trial NCT04575051?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04575051 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss, Age-Related

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04575051's enrollment target sits among peer trials

684 151st of 2000 higher than 1,850 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06795087 · 684 participants

    Discharge Medication Use Post-Operatively in GU Cancer Patients

  • NCT05099770 · 685 participants · Phase 3

    Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

  • NCT05880199 · 685 participants

    BSGM to Evaluate Patients With GI Symptoms

  • NCT04333537 · 686 participants · Phase 2

    Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04575051, the US trial registry maintained by the National Library of Medicine. NCT04575051 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.